D04.9 Código facturable y específico Carcinoma in situ of skin, unspecified
ICD-10-CM D04.9 identifies “Carcinoma in situ of skin, unspecified” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 2: Neoplasms
Instrucciones del código
Sin notas adicionales.
Instrucciones de niveles superiores
Capítulos 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
D00-D09 · In situ neoplasms (D00-D09)
Includes4
- Bowen's disease
- erythroplasia
- grade III intraepithelial neoplasia
- Queyrat's erythroplasia
D04 · Carcinoma in situ of skin
Referencias del índice oficial
Referencias del índice oficial (8)
Adenocarcinoma (1)
- Adenocarcinoma › apocrine › in situ › unspecified siteÍndice de enfermedades
Neoplasm, neoplastic (7)
- Neoplasm, neoplastic › connective tissue NEC › skin(dermis) NECNeoplasias
- Neoplasm, neoplastic › nailNeoplasias
- Neoplasm, neoplastic › scar NECNeoplasias
- Neoplasm, neoplastic › skin NOSNeoplasias
- Neoplasm, neoplastic › skin NOS › limb NECNeoplasias
- Neoplasm, neoplastic › sudoriferous, sudoriparous gland, site unspecifiedNeoplasias
- Neoplasm, neoplastic › sweat gland(apocrine) (eccrine), site unspecifiedNeoplasias
Historial
Historial del código
Sin cambios desde la primera aparición
ModificadoSin cambios
FY2016
Vigente desde
- Primera aparición
Carcinoma in situ of skin, unspecified
Código de diagnóstico facturable
CDC/NCHS · FY2016Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Sin cambios tabulares |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Sin cambios tabulares |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Sin cambios tabulares |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Sin cambios tabulares |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Sin cambios tabulares |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Sin cambios tabulares |
| FY2026 | 2025-10-01 | Sin cambios tabulares |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Correspondencias históricas ICD-9 · 2018
Solo correspondencia histórica; no sustituye códigos automáticamente.
- 232.9 · Aproximada
Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.